Pfizer Inc.PFENYSE
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | -146.54% |
| Q3 2025 | 21.68% |
| Q2 2025 | -1.92% |
| Q1 2025 | 636.23% |
| Q4 2024 | -90.99% |
| Q3 2024 | 18537.50% |
| Q2 2024 | -99.23% |
| Q1 2024 | 193.33% |
| Q4 2023 | -39.64% |
| Q4 2023 | -202.79% |
| Q3 2023 | -57.98% |
| Q2 2023 | 11.00% |
| Q4 2022 | -42.14% |
| Q4 2022 | -12.57% |
| Q3 2022 | 25.38% |
| Q2 2022 | 132.04% |
| Q4 2021 | -58.41% |
| Q4 2021 | 40.70% |
| Q3 2021 | 18.91% |
| Q2 2021 | 475.80% |
| Q4 2020 | -42.34% |
| Q3 2020 | -57.90% |
| Q2 2020 | 3.99% |
| Q1 2020 | 1095.55% |
| Q4 2019 | -104.39% |
| Q3 2019 | 52.20% |
| Q2 2019 | 29.95% |
| Q1 2019 | 1085.53% |
| Q4 2018 | -109.58% |
| Q3 2018 | 6.25% |
| Q3 2018 | 8.76% |
| Q2 2018 | -71.00% |
| Q4 2017 | 332.18% |
| Q4 2017 | -7.61% |
| Q3 2017 | -1.51% |
| Q2 2017 | 303.23% |
| Q4 2016 | -41.36% |
| Q4 2016 | -35.52% |
| Q3 2016 | -32.62% |
| Q2 2016 | 1866.28% |